A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Yohimbine
Benmoxin
Benmoxin may increase the orthostatic hypotensive activities of Fimasartan.
Yohimbine
Toloxatone
Toloxatone may increase the orthostatic hypotensive activities of Fimasartan.
Yohimbine
Pirlindole
Pirlindole may increase the orthostatic hypotensive activities of Fimasartan.
Yohimbine
Hydracarbazine
Hydracarbazine may increase the orthostatic hypotensive activities of Fimasartan.
Yohimbine
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the orthostatic hypotensive activities of Fimasartan.
Yohimbine
Nialamide
Nialamide may increase the orthostatic hypotensive activities of Fimasartan.
Yohimbine
Iproniazid
Iproniazid may increase the orthostatic hypotensive activities of Fimasartan.
Yohimbine
Clorgiline
Clorgiline may increase the orthostatic hypotensive activities of Fimasartan.
Yohimbine
Pargyline
Pargyline may increase the orthostatic hypotensive activities of Fimasartan.
Yohimbine
Loxoprofen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Loxoprofen.
Yohimbine
Flurbiprofen axetil
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Flurbiprofen axetil.
Yohimbine
NS-398
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with NS-398.
Yohimbine
SC-236
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with SC-236.
Yohimbine
Imidazole salicylate
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Imidazole salicylate.
Yohimbine
Acemetacin
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Acemetacin.
Yohimbine
Pirprofen
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Pirprofen.
Yohimbine
Benorilate
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Benorilate.
Yohimbine
Proquazone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Proquazone.
Yohimbine
Mofebutazone
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Mofebutazone.
Yohimbine
Carbaspirin calcium
The risk or severity of renal failure, hyperkalemia, and hypertension can be increased when Fimasartan is combined with Carbaspirin calcium.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3